CVS Shares Explode Higher Despite Lackluster Earnings Report

Shares of CVS Health Corp (NYSE:CVS) flew higher on Tuesday, following a mixed earnings report that was unexpectedly well-received by investors.

For the second quarter, CVS posted an adjusted profit of $1.32 per share, beating estimates of $1.30. Revenue rose 17.6% from last year to $43.73 billion, but still missed Wall Street’s view for $44.28 billion.

Looking ahead, the Woonsocket, RI-based company forecast third quarter earnings to range from $1.55 to $1.58, which is in-line with analyst expectations. For the full year 2016, the company lifted its guidance to a range of $5.81 to 5.89 per share, up from a prior estimate of $5.73 to 5.88. The analyst consensus is for $5.82 per share for the year.

Other interesting tidbits from the report included:

• Pharmacy Services Segment revs surged 20.7% to $29.5 billionm driven by higher claim volume and the Omnicare acquisition.
• Retail/LTC Segment revs rose 16.0% to $20.0 billion, also helped by Omnicare.
• Same store sales rose 2.1% in the period. Pharmacy same store sales rose 3.9%.
• Front store same store sales fell 2.5%, hurt by an earlier Easter this year.

CVS shares rose $3.95 (+4.23%) to $97.44 in late morning trading on Tuesday. The stock is flat year-to-date, versus a 6.4% gain in the S&P 500. CVS is the largest drug store operator in the U.S. with a market cap of over $106 billion.

You are viewing an abbreviated republication of ETF Daily News content. You can find full ETF Daily News articles on (www.etfdailynews.com)

Related posts:

1. BP plc (ADR)(BP) Earnings Report Creates Gap Higher
2. Silver Prices Explode Higher as Durable Goods Data Hints at Economic Slowdown
3. Apple Shares Surge as Earnings, Revenue, and Forecast All Beat Estimates
4. Papa John’s Int’l, Inc. (PZZA) Earnings Report Serves Up Profits
5. Ford Shares are Tanking on Lack of Guidance, Bad Q2 Earnings Miss

Powered by WPeMatico